Circulating GLP-1 Levels as a Potential Indicator of Metabolic Syndrome Risk in Adult Women

Glucagon-like peptide-1 (GLP-1), an incretin hormone, plays an important role in regulating glucose homeostasis. In this study, the applicability of circulating GLP-1 levels as an early indicator of metabolic syndrome (MetS) risk was examined. Women without diagnosed diseases were grouped according...

Full description

Saved in:
Bibliographic Details
Published in:Nutrients 2021-03, Vol.13 (3), p.865
Main Authors: Seon, Min Joo, Hwang, So Yoon, Son, Yujeong, Song, Juhyun, Kim, Oh Yoen
Format: Article
Language:English
Subjects:
Adipose tissue
Blood pressure
Body mass
Body mass index
Body size
C-reactive protein
Cardiovascular disease
Cholesterol
Chronic illnesses
Diabetes
Diet
early indicator
Gender differences
Glucagon
Glucagon-like peptide 1
Glucose
Homeostasis
Indicators
Insulin
Insulin resistance
Lipids
Menopause
Metabolic disorders
Metabolic syndrome
Nutrition research
Obesity
Peptides
Plasma
Population studies
Risk analysis
Risk factors
women
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Glucagon-like peptide-1 (GLP-1), an incretin hormone, plays an important role in regulating glucose homeostasis. In this study, the applicability of circulating GLP-1 levels as an early indicator of metabolic syndrome (MetS) risk was examined. Women without diagnosed diseases were grouped according to their number of MetS risk factors (MetS RFs) (no RFs as Super-healthy, = 61; one or two RFs as MetS risk carriers, = 60; 3 ≤ RFs as MetS, = 19). The circulating GLP-1 levels and homeostasis model assessment insulin resistance (HOMA-IR) scores were significantly higher in the MetS group than in the other two groups. The GLP-1 levels correlated positively with adiposity, HOMA-IR, blood pressure, and high sensitivity C-reactive protein (hs-CRP), but not with fasting glucose and lipid profiles, whose significances were maintained after adjustments for age, smoking and drinking habits, menopausal status, and total calorie intake. The GLP-1 levels also increased proportionally with the number of MetS RFs. In the MetS group, the GLP-1 levels were much higher in individuals with obesity (body mass index ≥ 25 kg/m ). In conclusion, the circulating GLP-1 level may be applicable as a potential early indicator of MetS risk in women without diagnosed diseases. Further study with a large population is needed to confirm the conclusion.
ISSN:2072-6643
2072-6643
DOI:10.3390/nu13030865